NBIX vs TEX · P/E 45, rev $2.36B vs P/E 31, rev $5.13B
Neurocrine Biosciences Inc (NBIX) versus Terex Corporation (TEX) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Terex Corporation (TEX) is a farm & heavy construction machinery company listed on NYSE.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported TEX revenue for 2024-12-31 was $5.13B. Net income was $335.0M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. TEX currently screens at market cap $7.33B and trailing P/E 31.3.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. TEX currently screens at market cap $7.33B and trailing P/E 31.3.
Not investment advice. Open the NBIX and TEX stock pages for the full models.
Not investment advice.